Objectives
Adult onset-Still's disease (AOSD) and gout are considered as auto-inflammatory disorders. Both diseases run recurrent episodic course and respond to anti-IL 1 treatment. Additionally, increased frequency of MEFV variations in other inflammatory diseases other than FMF such as Behçet's disease, ulcerative colitis and rheumatoid arthritis and raises the possibility that MEFV gene may play a general role in the inflammatory pathway. Therefore in this study, we explored the MEFV exon 2 and 10 variations in a group of AOSD and gout patients and compared the frequencies between disease groups and healthy controls.
Patients and methods
We studied all consecutive 42 patients with FMF (mean age: 33.3 ± 15.2), 28 patients with adult onset Still's disease (mean age: 37.9±8.4), 29 patients with gout (mean age: 50.3 ± 9.7), and 44 healthy controls (mean age: 33.6±10.2). Genomic DNA was isolated from venous blood, using basic salting-out technique. PCR amplifications were done in three sets of primers covering exon 2 and exon 10 regions. Gel purified products were Sanger sequenced and chromatograms were analysed using Genious Software by two independent researchers. MEFV variation frequencies were calculated using chi-square analysis.
Results
The frequency of common exon 2 variation E148Q was found to be similar between the study groups (FMF: 5%, AOSD: 4%, gout: 3% and healthy controls: 3%). In exon 2, only R202Q variation was significantly more frequent in FMF group (43%) compared to other groups (18-25%) (P=0.004).
There was also significant difference in pathogenic exon 10 variations between FMF and other groups. The most prominent of these variations, M694V, was significantly more common in FMF group (49%), compared to AOSD (2%), gout (7 %) and healthy controls (1 %) (P<0.0001). The frequency of non-synonymous variations such as D102D-G138G-A165A, the common haplotype, was more likely to be more common in FMF group (66%) compared to AOSD (22%), gout (30%) and healthy controls (38%) (p < 0.05).
Conclusions
AOSD and gout do not seem to be associated with MEFV gene mutations.
